Corrigendum
In the June 2008 issue, the surname of the third author was published as “Vagelli”. This should have appeared as “Vaggelli”.
Additional information
The online version of the original article can be found at 10.1038/ncpendmet0816
Rights and permissions
About this article
Cite this article
Falchetti, A., Cilotti, A., Vagelli, L. et al. Erratum: A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Rev Endocrinol 4, 420 (2008). https://doi.org/10.1038/ncpendmet0888
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0888
This article is cited by
-
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)
Endocrine (2016)
-
Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects
Endocrine (2011)
-
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism
Endocrine (2011)
